What You Need to Know About XBB.1.5, the Latest Omicron Variant
XBB.1.5 is the most transmissible variant of COVID-19 yet. As 2023 begins, it’s causing the majority of cases in the U.S., but we aren’t seeing a surge like omicron caused last winter.
Financing, supply, policy, advocacy, and communication to improve health and survival with life saving vaccines worldwide
Explore the latest public health research and insights about vaccines.
XBB.1.5 is the most transmissible variant of COVID-19 yet. As 2023 begins, it’s causing the majority of cases in the U.S., but we aren’t seeing a surge like omicron caused last winter.
Looking for prominent public health experts in the field of vaccines? They’re here at the Bloomberg School of Public Health.
Anna Durbin, MD, studies experimental vaccines for SARS-CoV-2, dengue, West Nile, Zika, malaria, and more in human clinical trials and in controlled human infection studies.
Daniel Salmon, PhD ’03, MPH, is a vaccinologist who conducts epidemiological and behavioral studies to assess the safety of vaccines and improve vaccine decision-making.